Your browser doesn't support javascript.
loading
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.
Scorletti, Eleonora; Afolabi, Paul R; Miles, Elizabeth A; Smith, Debbie E; Almehmadi, Amal; Alshathry, Albandri; Moyses, Helen E; Clough, Geraldine F; Wright, Mark; Patel, Janisha; Bindels, Laure; Delzenne, Nathalie M; Calder, Philip C; Byrne, Christopher D.
Afiliação
  • Scorletti E; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, So
  • Afolabi PR; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, UK.
  • Miles EA; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Smith DE; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, So
  • Almehmadi A; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Alshathry A; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Moyses HE; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, Southampton, UK.
  • Clough GF; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Wright M; Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Patel J; Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Bindels L; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Delzenne NM; Metabolism and Nutrition Research Group, Louvain Drug Research Institute, Université Catholique de Louvain, Brussels, Belgium.
  • Calder PC; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, So
  • Byrne CD; Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK; National Institute for Health Research Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton National Health Service (NHS) Foundation Trust, So
Contemp Clin Trials ; 71: 113-123, 2018 08.
Article em En | MEDLINE | ID: mdl-29787859
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligossacarídeos / RNA Ribossômico 16S / Trato Gastrointestinal / Hepatopatia Gordurosa não Alcoólica / Microbioma Gastrointestinal / Bifidobacterium animalis / Fígado Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligossacarídeos / RNA Ribossômico 16S / Trato Gastrointestinal / Hepatopatia Gordurosa não Alcoólica / Microbioma Gastrointestinal / Bifidobacterium animalis / Fígado Idioma: En Ano de publicação: 2018 Tipo de documento: Article